Bones: Medicaid DXA Cuts Jeopardize Osteoporosis Care
If Medicaid reimbursement cuts for dual X-ray absorptiometry (DXA) are not reversed, experts predict a surge in osteoporotic fractures that will raise costs far beyond the DXA cost savings...
Procedures: Data from KANON Patients Blow Hole in ACL Repair
Surgical reconstruction was not better than training alone for restoring muscle strength and function after ACL injury...
Arthritis: RA Improving Due to Better Management, Not New Drugs
Better monitoring and more aggressive use of old drugs, especially methotrexate, have contributed more to recent improvements in RA outcomes in Spain than the arrival of new drugs such as TNF inhibitors...
Consumer News: Bone Finding May Point to Hope for Osteoporosis
Serotonin formed in the gut, whose use has long been a mystery to researchers, may play a critical role in bone formation...
BioPharm Business: FDA Panel Okays Febuxostat for Gout
A US FDA panel voted 12-0 this week to recommend approval of Takeda Pharmaceutical's febuxostat (Uloric), the first new gout drug in 40 years...
|